Copertina

Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Nina Dominik, Lorenz Balcar, Georg Semmler, Benedikt Simbrunner, Michael Schwarz, Benedikt S. Hofer, Lukas Hartl, Mathias Jachs, Bernhard Scheiner, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Alexander Pilger, Thomas Reiberger
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Alimentary Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
di: Nina Dominik, et al.
Pubblicazione: (2024)

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
di: Lukas Hartl, et al.
Pubblicazione: (2024)

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
di: Mathias Jachs, et al.
Pubblicazione: (2025)

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease
di: Benedikt Simbrunner, et al.
Pubblicazione: (2025)

The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study
di: David J. M. Bauer, et al.
Pubblicazione: (2024)

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
di: Benedikt Silvester Hofer, et al.
Pubblicazione: (2024)

Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End‐Stage Liver Disease—Authors' Reply
di: Mattias Mandorfer, et al.
Pubblicazione: (2025)

Editorial: Carvedilol Remains the First‐Line Treatment of Portal Hypertension After the CALIBRE Trial
di: Thomas Reiberger, et al.
Pubblicazione: (2025)

Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
di: Lukas Burghart, et al.
Pubblicazione: (2024)

Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation
di: Benedikt Silvester Hofer, et al.
Pubblicazione: (2026)

Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Authors' Reply
di: Lucie Simonis, et al.
Pubblicazione: (2025)

Smoking Aggravates Inflammation, Fibrogenesis, Angiogenesis and Cancer Risk in Patients With Cirrhosis
di: Nina Dominik, et al.
Pubblicazione: (2025)

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation
di: Lucie Simonis, et al.
Pubblicazione: (2025)

Research Communication: The Cumulated Spontaneous Portosystemic Shunts ( SPSS ) Area Decreases After TIPS and Impacts on Prognosis
di: Marlene Hintersteininger, et al.
Pubblicazione: (2025)

Letter: Zinc and selenium—Potential biomarkers for chronic liver disease?
di: Zhuo Li, et al.
Pubblicazione: (2024)

Impact of Underlying Portal Hypertension on Severity and Course of Acute‐On‐Chronic Liver Failure
di: Vlad Taru, et al.
Pubblicazione: (2025)

Characterisation and Prognostic Implication of Cholestasis After Burn Injury
di: Lorenz Semmler, et al.
Pubblicazione: (2026)

Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma
di: Katharina Pomej, et al.
Pubblicazione: (2024)

Review article: Oesophageal disorders in chronic liver disease
di: Francisco Idalsoaga, et al.
Pubblicazione: (2024)

Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
di: Jian Wang, et al.
Pubblicazione: (2024)

Duke Activity Status Index and Liver Frailty Index predict mortality in ambulatory patients with advanced chronic liver disease: A prospective, observational study
di: Felicity R. Williams, et al.
Pubblicazione: (2024)

Alcohol Use After TIPS Implantation Significantly Increases the Risk of ACLF and Liver‐Related Death
di: Caroline Schwarz, et al.
Pubblicazione: (2025)

Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’: Authors' Reply
di: Lukas Burghart, et al.
Pubblicazione: (2026)

Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease
di: Jannis Kountouras, et al.
Pubblicazione: (2024)

Racial and ethnic disparities in post‐liver transplant outcomes for patients with acute‐on‐chronic liver failure: An analysis of the UNOS database
di: David Uihwan Lee, et al.
Pubblicazione: (2024)

Prognostication of Liver Disease Patients via the WFUMB ‘Rule‐of‐4’ Algorithm Using SSI ‐ 2D ‐ SWE ‐Based Liver Stiffness Measurement
di: Christian Sebesta, et al.
Pubblicazione: (2026)

Letter: Potential impact of Helicobacter pylori infection on oesophageal disorders in chronic liver disease
di: Jannis Kountouras, et al.
Pubblicazione: (2024)

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
di: Stuart McPherson, et al.
Pubblicazione: (2024)

Letter: Post‐Banding Ulcer Bleeding Is More Common With Urgent EBL and Renal Dysfunction
di: Jurij Maurer, et al.
Pubblicazione: (2026)

Letter: Potential impact ofHelicobacter pyloriinfection on oesophageal disorders in chronic liver disease—Authors' reply
di: Francisco Idalsoaga, et al.
Pubblicazione: (2024)

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
di: Lisa Sandmann, et al.
Pubblicazione: (2024)

Identification of four novel acute‐on‐chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methods
di: Nipun Verma, et al.
Pubblicazione: (2024)

UK guideline on the transition and management of childhood liver diseases in adulthood
di: Deepak Joshi, et al.
Pubblicazione: (2024)

Editorial: Paradox of liver fat content in the spectrum of non‐alcoholic fatty liver disease
di: Sung Won Chung, et al.
Pubblicazione: (2024)

Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply
di: Matthias Lenfant, et al.
Pubblicazione: (2024)

Editorial: Novel insights into the prognostic relevance of high‐dose PPI treatment in patients with cirrhosis
di: Dominik Bettinger, et al.
Pubblicazione: (2024)

Editorial: Muscles at the expense of liver injury. Is it worth it?
di: C. Stephens
Pubblicazione: (2024)

Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
di: Nobuharu Tamaki, et al.
Pubblicazione: (2024)

Long‐term clinical outcomes in steatotic liver disease and incidence of liver‐related events, cardiovascular events and all‐cause mortality
di: Nobuharu Tamaki, et al.
Pubblicazione: (2024)

Editorial: Foretelling the future—Emerging role of magnetic resonance enterography as a prognostic tool in Crohn's disease
di: Siri A. Urquhart, et al.
Pubblicazione: (2024)